Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Devonian Health Group Inc DVHGF


Primary Symbol: V.GSD

Healthcare
Devonian Health Group Inc. is a Canada-based late-stage botanical pharmaceutical company. The Company's main activity is the development of botanical drugs from plant materials and algae for the treatment of inflammatory-autoimmune diseases, including ulcerative colitis and atopic dermatitis. It is also involved in the development of value-added products for dermo-cosmetics and the distribution... see more

Recent & Breaking News (TSXV:GSD)

Devonian announces the trading of its shares will resume on Monday February 27th, 2018

GlobeNewswire February 23, 2018

Aspri Pharma Canada Inc. Announces Acquisition of Subordinate Voting Shares of Devonian Health Group Inc.

GlobeNewswire February 13, 2018

Biopharma acquisition provides commercialization edge

Stockhouse Editorial February 6, 2018

Devonian Announces Acquisition of Altius Healthcare

GlobeNewswire February 1, 2018

IIROC Trading Halt - GSD

Canada NewsWire January 31, 2018

IIROC Trade Halt - Devonian Health Group Inc.

Newsfile January 31, 2018

Devonian Announces voting results of the Annual General and Special Meeting

GlobeNewswire January 12, 2018

Devonian Announces the Filing of New Patent Application for Thykamine™

GlobeNewswire November 16, 2017

Devonian Announces Initiation of Phase IIa Clinical Trial of Thykamine™ in Adult patients with Mild-to-Moderate Atopic Dermatitis

GlobeNewswire November 9, 2017

InvestmentPitch Media Invites Investors to the GCFF Conference in Toronto on September 30, 2017 - Video Hosted on InvestmentPitch.com

Newsfile September 28, 2017

Devonian Health secures Purgenesis™ anti-aging partnership

Stockhouse Editorial September 28, 2017

Devonian Health Announces Purgenesis™ anti-aging treatment marketing and distribution partnership

GlobeNewswire September 28, 2017

Devonian Health Group to present at GCFF (Global Chinese Financial Conference) 18th annual conference

GlobeNewswire September 14, 2017

Devonian Health Group’s Purgenesis™ anti-aging derma-cosmeceutical treatment is now recognized through the Canadian Dermatology Association Skin Health Program

GlobeNewswire September 6, 2017

Farm to Pharm: the Pharmaceutical Revolution

Jeff Nielson September 5, 2017

Devonian Health Group Announces Closing of Private Placement

MarketWire Canada July 12, 2017

Devonian Announces Grant of Options

MarketWire Canada July 7, 2017

Devonian Announces Plans for its Dermatology program of Thykamine(TM)

MarketWire Canada June 22, 2017

Devonian Announces Issuance of One New Key Patent and the Granting of a Trademark

MarketWire Canada June 21, 2017

Devonian Announces the Appointment of Two New Members to the Board of Directors and Senior Management Changes to Support Growth Strategy

MarketWire Canada May 31, 2017